What is the projected market valuation for the US viral vectors-and-plasmid-DNA-manufacturing market by 2035?

The projected market valuation is $440.7 Million by 2035. Read More

What was the overall market valuation in 2024?

The overall market valuation was $112.0 Million in 2024. Read More

Which application segment is projected to have the highest valuation by 2035?

The Cell and Gene Editing application segment is projected to reach $140.7 Million by 2035. Read More

What are the key players in the US viral vectors-and-plasmid-DNA-manufacturing market?

Key players include Lonza Group, Sartorius AG, Thermo Fisher Scientific, and Merck KGaA. Read More

Which type of viral vector is expected to dominate the market by 2035?

Plasmid DNA is expected to dominate the market, projected to reach $200.0 Million by 2035. Read More

What is the projected valuation for the Vaccine Development application segment by 2035?

The Vaccine Development application segment is projected to reach $120.0 Million by 2035. Read More

Which technology segment is anticipated to show significant growth by 2035?

The Liposomal Delivery technology segment is anticipated to grow to $140.7 Million by 2035. Read More

What is the expected valuation for the Biotechnology Firms end-use segment by 2035?

The Biotechnology Firms end-use segment is expected to reach $120.0 Million by 2035. Read More

How does the market valuation in 2035 compare to that in 2024?

The market valuation in 2035 is expected to be significantly higher, increasing from $112.0 Million in 2024 to $440.7 Million. Read More

US Viral Vectors and Plasmid DNA Manufacturing Market

Q: What is the expected CAGR for the US viral vectors-and-plasmid-DNA-manufacturing market during the forecast period 2025 - 2035?

The expected CAGR is 13.26% during the forecast period 2025 - 2035. Read More

ID: MRFR/HC/18205-HCR

100 Pages

Vikita Thakur

Last Updated: April 06, 2026

US Viral Vectors and Plasmid DNA Manufacturing Market Research Report By Vector Type (Plasmid DNA, Viral Vector, Non-viral Vector), By Disease Type (Cancer, Genetic Disorder, Infectious Disease), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research), By Workflow (Upstream Processing, Downstream Processing) and By End-User (Pharmaceutical and Biopharmaceutical Companies, Research Institutes) - Growth & Industry Forecast 2025 To 2035

US Viral Vectors and Plasmid DNA Manufacturing Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Application (USD Million)
  1. 4.1.1 Gene Therapy
  2. 4.1.2 Vaccine Development
  3. 4.1.3 Transgenic Research
  4. 4.1.4 Cell and Gene Editing
2. 4.2 Medical Device, BY Type (USD Million)
  1. 4.2.1 Viral Vectors
  2. 4.2.2 Plasmid DNA
  3. 4.2.3 RNA-based Vectors
3. 4.3 Medical Device, BY Technology (USD Million)
  1. 4.3.1 Viral Transduction
  2. 4.3.2 Electroporation
  3. 4.3.3 Microinjection
  4. 4.3.4 Liposomal Delivery
4. 4.4 Medical Device, BY End-Use (USD Million)
  1. 4.4.1 Pharmaceutical Companies
  2. 4.4.2 Biotechnology Firms
  3. 4.4.3 Research Institutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Lonza Group (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Sartorius AG (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Thermo Fisher Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Merck KGaA (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Boehringer Ingelheim (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cobra Biologics (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Viva Biotech (CN)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 GenScript Biotech (CN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Abcam plc (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY TYPE
4. 6.4 US MARKET ANALYSIS BY TECHNOLOGY
5. 6.5 US MARKET ANALYSIS BY END-USE
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY TECHNOLOGY, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END-USE, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END-USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Medical Device Market Segmentation

Medical Device By Application (USD Million, 2025-2035)

Gene Therapy
Vaccine Development
Transgenic Research
Cell and Gene Editing

Medical Device By Type (USD Million, 2025-2035)

Viral Vectors
Plasmid DNA
RNA-based Vectors

Medical Device By Technology (USD Million, 2025-2035)

Viral Transduction
Electroporation
Microinjection
Liposomal Delivery

Medical Device By End-Use (USD Million, 2025-2035)

Pharmaceutical Companies
Biotechnology Firms
Research Institutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”